226 related articles for article (PubMed ID: 31650043)
1. Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
Mishra MV; Khairnar R; Bentzen SM; Larson G; Tsai H; Sinesi C; Vargas C; Laramore G; Rossi C; Rosen L; Zhu M; Hartsell W
Clin Transl Radiat Oncol; 2019 Nov; 19():80-86. PubMed ID: 31650043
[TBL] [Abstract][Full Text] [Related]
2. Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09.
Mishra MV; Khairnar R; Bentzen SM; Larson G; Tsai H; Sinesi C; Vargas C; Laramore G; Rossi C; Rosen L; Sun K; Hartsell W
Clin Transl Radiat Oncol; 2020 May; 22():50-54. PubMed ID: 32258443
[TBL] [Abstract][Full Text] [Related]
3. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer.
Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N
Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899
[TBL] [Abstract][Full Text] [Related]
4. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
[TBL] [Abstract][Full Text] [Related]
5. A pooled patient-reported outcomes analysis of moderately hypofractionated proton beam therapy and photon-based intensity modulated radiation therapy for low- or intermediate-risk prostate cancer.
Lukez A; Handorf E; Mendenhall NP; Henderson RH; Stish BJ; Davis BJ; Hallman M; Horwitz EM; Vapiwala N; Wong JK
Prostate; 2024 Mar; 84(4):395-402. PubMed ID: 38108113
[TBL] [Abstract][Full Text] [Related]
6. Extreme hypofractionated proton radiotherapy for prostate cancer using pencil beam scanning: Dosimetry, acute toxicity and preliminary results.
Kubeš J; Vondráček V; Andrlik M; Navrátil M; Sláviková S; Vítek P; Rosina J; Abrahámová J; Prausová J; Grebenyuk A; Dědečková K
J Med Imaging Radiat Oncol; 2019 Dec; 63(6):829-835. PubMed ID: 31486267
[TBL] [Abstract][Full Text] [Related]
7. Prostate Cancer Treatment with Pencil Beam Proton Therapy Using Rectal Spacers sans Endorectal Balloons.
Forsthoefel M; Hankins R; Ballew E; Frame C; DeBlois D; Pang D; Krishnan P; Unger K; Kowalczyk K; Lynch J; Dritschilo A; Collins SP; Lischalk JW
Int J Part Ther; 2022; 9(1):28-41. PubMed ID: 35774493
[TBL] [Abstract][Full Text] [Related]
8. Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry.
Chhabra AM; Rice SR; Holtzman A; Choi JI; Hasan S; Press RH; Chang J; Halasz L; Tsai HK; Wang CJ; Kabolizadeh P; Gondi V; Hartsell WF; Vora SA; Vargas CE; Simone CB
Radiother Oncol; 2023 Jun; 183():109551. PubMed ID: 36813169
[TBL] [Abstract][Full Text] [Related]
9. Comparison of clinical outcomes between passive scattering versus pencil-beam scanning proton beam therapy for hepatocellular carcinoma.
Yoo GS; Yu JI; Cho S; Jung SH; Han Y; Park S; Oh Y; Lee B; Park HC; Lim DH; Choi MS; Won H
Radiother Oncol; 2020 May; 146():187-193. PubMed ID: 32179362
[TBL] [Abstract][Full Text] [Related]
10. Early and late side effects, dosimetric parameters and quality of life after proton beam therapy and IMRT for prostate cancer: a matched-pair analysis.
Dutz A; Agolli L; Baumann M; Troost EGC; Krause M; Hölscher T; Löck S
Acta Oncol; 2019 Jun; 58(6):916-925. PubMed ID: 30882264
[No Abstract] [Full Text] [Related]
11. Proton therapy- the modality of choice for future radiation therapy management of Prostate Cancer?
Mangan S; Leech M
Tech Innov Patient Support Radiat Oncol; 2019 Sep; 11():1-13. PubMed ID: 32095544
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Estimated Late Toxicities between IMPT and IMRT Based on Multivariable NTCP Models for High-Risk Prostate Cancers Treated with Pelvic Nodal Radiation.
Chilukuri S; Sundar S; Patro K; Sawant M; Sivaraman R; Arjunan M; Panda PK; Sharma D; Jalali R
Int J Part Ther; 2022; 9(1):42-53. PubMed ID: 35774485
[TBL] [Abstract][Full Text] [Related]
13. Initial report of the genitourinary and gastrointestinal toxicity of post-prostatectomy proton therapy for prostate cancer patients undergoing adjuvant or salvage radiotherapy.
Deville C; Jain A; Hwang WT; Woodhouse KD; Both S; Wang S; Gabriel PE; Christodouleas JP; Bekelman J; Tochner Z; Vapiwala N
Acta Oncol; 2018 Nov; 57(11):1506-1514. PubMed ID: 30028227
[TBL] [Abstract][Full Text] [Related]
14. Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trial.
Pugh TJ; Choi S; Nogueras-Gonzalaez GM; Nguyen QN; Mahmood U; Frank SJ; Mathai B; Zhu XR; Sahoo N; Gillin M; Kuban DA; Hoffman KE; McGuire SE; Lee AK
Int J Part Ther; 2016; 3(1):27-36. PubMed ID: 31772973
[TBL] [Abstract][Full Text] [Related]
15. Reirradiation With Proton Therapy for Recurrent Malignancies of the Esophagus and Gastroesophageal Junction: Results of the Proton Collaborative Group Multi-Institutional Prospective Registry Trial.
Hotca A; Sindhu KK; Lehrer EJ; Hartsell WF; Vargas C; Tsai HK; Chang JH; Apisarnthanarax S; Nichols RC; Chhabra AM; Hasan S; Press RH; Lazarev S; Hajj C; Kabarriti R; Rule WG; Simone CB; Choi JI
Adv Radiat Oncol; 2024 May; 9(5):101459. PubMed ID: 38596455
[TBL] [Abstract][Full Text] [Related]
16. Pencil Beam Scanning (PBS) Intensity-Modulated Proton Therapy (IMPT) Chemoradiotherapy for Anal Canal Cancer-Single Institution Experience.
Vítek P; Kubeš J; Vondráček V; Andrlik M; Navrátíl M; Zapletal R; Haas A; Dědečková K; Ondrová B; Grebenyuk A; Rosina J
Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008349
[No Abstract] [Full Text] [Related]
17. Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer.
Pugh TJ; Munsell MF; Choi S; Nguyen QN; Mathai B; Zhu XR; Sahoo N; Gillin M; Johnson JL; Amos RA; Dong L; Mahmood U; Kuban DA; Frank SJ; Hoffman KE; McGuire SE; Lee AK
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):946-53. PubMed ID: 24139077
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes in Patients with Recurrent Glioblastoma Treated with Proton Beam Therapy Reirradiation: Analysis of the Multi-Institutional Proton Collaborative Group Registry.
Saeed AM; Khairnar R; Sharma AM; Larson GL; Tsai HK; Wang CJ; Halasz LM; Chinnaiyan P; Vargas CE; Mishra MV
Adv Radiat Oncol; 2020; 5(5):978-983. PubMed ID: 33083661
[TBL] [Abstract][Full Text] [Related]
19. Initial Report of Pencil Beam Scanning Proton Therapy for Posthysterectomy Patients With Gynecologic Cancer.
Lin LL; Kirk M; Scholey J; Taku N; Kiely JB; White B; Both S
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):181-189. PubMed ID: 26372435
[TBL] [Abstract][Full Text] [Related]
20. Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.
Chuong MD; Hartsell W; Larson G; Tsai H; Laramore GE; Rossi CJ; Wilkinson JB; Kaiser A; Vargas C
Acta Oncol; 2018 Mar; 57(3):368-374. PubMed ID: 29034790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
